Pharmaceutical composition containing pentoxifylline and carbazochrome sodium sulfonate and application thereof

A technology of pentoxifylline and sodium carboxylate, which is applied in the field of medicine to achieve the effects of significant anti-inflammatory effect, regulating activity and reducing toxic and side effects

Active Publication Date: 2011-07-20
LUNAN PHARMA GROUP CORPORATION
View PDF1 Cites 3 Cited by
  • Summary
  • Abstract
  • Description
  • Claims
  • Application Information

AI Technical Summary

Problems solved by technology

[0006] Among the existing medicines for the treatment of hemorrhoids, there are no medicines with pentoxifylline and carbosulfonate as active ingredients.

Method used

the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
View more

Image

Smart Image Click on the blue labels to locate them in the text.
Viewing Examples
Smart Image
  • Pharmaceutical composition containing pentoxifylline and carbazochrome sodium sulfonate and application thereof
  • Pharmaceutical composition containing pentoxifylline and carbazochrome sodium sulfonate and application thereof
  • Pharmaceutical composition containing pentoxifylline and carbazochrome sodium sulfonate and application thereof

Examples

Experimental program
Comparison scheme
Effect test

Embodiment 1

[0023] The experiment of embodiment 1 rat croton oil hemorrhoid model

[0024] experimental method:

[0025] 50 SD rats (about 200 grams) are randomly divided into five groups according to body weight: model control group, pentoxifylline group (2% pentoxifylline glycerin solution, each administration 0.6ml), sodium carbosulfate group ( 1% sodium carbene sulfonate glycerin solution, each administration 0.6ml), composition group (glycerol solution of the composition, containing pentoxifylline 2%, carbene sulfonate sodium 1%, each administration 0.6ml), Mayinglong group (manufactured by Mayinglong Musk Hemorrhoid Ointment Wuhan Mayinglong Pharmaceutical Group Co., Ltd., Z42021920, batch number 080615, specification: 10g / tube), 10 in each group. Intrarectal administration to rats two days in advance, twice a day at 9:00 am and 21:00 pm, soaked with 10 mg cotton balls and stuffed into the rectum. There are cotton balls (if there are cotton balls, they should be removed). The las...

Embodiment 2

[0037] Example 2 Xylene Anti-inflammatory Experiment in Mice

[0038] Perianal pain caused by perianal inflammation is one of the symptoms of hemorrhoids, and detecting the anti-inflammatory effect of the composition can reflect the therapeutic effect of the composition. In the present invention, the anti-inflammatory effect of the medicine is detected by a mouse xylene anti-inflammatory experiment.

[0039] experimental method:

[0040] 40 KM mice, half male and half female, body weight 25-30 grams, were randomly divided into four groups according to body weight, i.e. model control group, pentoxifylline group (1.2% pentoxifylline glycerin solution), sodium carbosulfate group ( 2% sodium carbosulfate glycerin solution), composition group (glycerin solution of the composition, containing 1.2% pentoxifylline, 2% sodium carbosulfate), 10 rats in each group. Take 20 μl of xylene and apply it to the right ear of each mouse. After 30 minutes, take 0.03ml of each test drug and app...

Embodiment 3

[0047] The effect of embodiment 3 composition on rat perianal ulcer caused by acetic acid

[0048] Take 60 rats, half male and half male, weighing 200-250 g. Take the filter paper and use a puncher with an inner diameter of 6mm to make filter paper pieces of equal size, put them into 99.0% acetic acid solution and soak them fully, put the soaked filter paper pieces around the anus, so that the filter paper pieces are in close contact with the perianal skin and mucous membranes, Use one piece of filter paper each time, change the filter paper after 1 min for each rat, and remove the filter paper after 0.5 min. On the 2nd day, the rats were randomly divided into 6 groups, 10 in each group, and the high and low dose groups of the composition were respectively given high concentration (composition glycerin solution, containing 1.8% pentoxifylline+0.6% sodium carbosulfonate), low concentration (composition glycerin solution, 1.2% pentoxifylline+0.4% carbosulfonate sodium solution)...

the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
Login to view more

PUM

No PUM Login to view more

Abstract

The invention belongs to the field of medicine, and relates to a pharmaceutical composition containing pentoxifylline and carbazochrome sodium sulfonate and application thereof. The pharmaceutical composition contains the active components pentoxifylline and carbazochrome sodium sulfonate, has the efficacies of diminishing inflammation, arresting bleeding, improving the vascular permeability and the like in treating hemorrhagic hemorrhoids, is obviously superior to the single drugs of pentoxifylline and carbazochrome sodium sulfonate in therapeutic action, and has a synergistic action.

Description

technical field [0001] The invention belongs to the field of medicine and relates to a western medicine composition and its application, in particular to a pharmaceutical composition containing pentoxifylline and carbosulfonium sodium and its application. Background technique [0002] Hemorrhoids are a common and frequently-occurring disease. Since ancient times, there has been a saying that "nine out of ten people have hemorrhoids". Hemorrhoids are clumps formed by pathological hypertrophy and displacement of anal cushions and blood stasis in the perianal subcutaneous vascular plexus. The main clinical manifestations are blood in the stool, pain, edema, swelling, pruritus, increased secretions and prolapse. Relevant studies have shown that the incidence rate of hemorrhoids in my country is about 46%, and in some areas, it is as high as 70% among adults; the survey data of the incidence rate in Europe, America and Japan is about 40%-60%. Symptoms such as hematochezia, prola...

Claims

the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
Login to view more

Application Information

Patent Timeline
no application Login to view more
Patent Type & Authority Applications(China)
IPC IPC(8): A61K31/522A61K31/404A61P9/14
Inventor 赵志全
Owner LUNAN PHARMA GROUP CORPORATION
Who we serve
  • R&D Engineer
  • R&D Manager
  • IP Professional
Why Eureka
  • Industry Leading Data Capabilities
  • Powerful AI technology
  • Patent DNA Extraction
Social media
Try Eureka
PatSnap group products

Browse by: Latest US Patents, China's latest patents, Technical Efficacy Thesaurus, Application Domain, Technology Topic.

© 2024 PatSnap. All rights reserved.Legal|Privacy policy|Modern Slavery Act Transparency Statement|Sitemap